Company Encyclopedia
View More
name
MEIHUABIO;Mei Hua Group
600873.SH
MeiHua Holdings Group Co.,Ltd, together with its subsidiaries, manufactures nutritional products and solutions in China and internationally. The company offers amino acids; l-threonine and l-lysine for livestock; umami agents comprising monosodium glutamate and I+G; food ingredients consisting of l-glutamine, l-proline, l-valine, isoleucine, adenosine, guanosine, and inosine; and colloids and polysaccharides, such as food-grade and industrial-grade xanthan gums, pullulan, and trehalose. It also provides livestock health products, including riboflavin, and feed-grade isoleucine and valine; plant-based protein, such as corn germ, corn gluten meal and feed, and MSG by-products; and organic fertilizers. In addition, the company engages in technological development; trading; investment; and warehousing.
1.888 T
600873.SHMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Specialty ChemicalsIndustry
Industry Ranking7/154
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE24.45%A
    • Profit Margin15.32%A
    • Gross Margin17.30%D
  • Growth ScoreC
    • Revenue YoY-5.06%D
    • Net Profit YoY25.02%B
    • Total Assets YoY10.44%B
    • Net Assets YoY9.50%B
  • Cash ScoreC
    • Cash Flow Margin652.59%C
    • OCF YoY-5.06%D
  • Operating ScoreA
    • Turnover0.99A
  • Debt ScoreB
    • Gearing Ratio38.00%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    MEIHUABIO has repurchased a total of 48.5471 million shares, completing its repurchase plan

    According to the announcement from Mei Hua Group, as of the close on September 2, 2025, the company's share repurchase plan has been completed. The company has repurchased a total of 48.5471 million shares, accounting for 1.70% of the company's total share capital. The highest repurchase price was RMB 10.97 per share, the lowest price was RMB 9.10 per share, and the average repurchase price was RMB 10.13 per share, with a total amount of funds used being RMB 492 million (excluding transaction fees)

    Zhitong·
    SH
    600873
    -0.30%
    Zhitong·
    SH
    600873
    -0.30%

    MEIHUABIO released its performance for the first half of the year, with a net profit attributable to the parent company of 1.768 billion yuan, a year-on-year increase of 19.96%

    MEIHUABIO released its semi-annual report for 2025, reporting operating revenue of 12.28 billion yuan, a year-on-year decrease of 2.87%; net profit attributable to shareholders of the parent company was 1.768 billion yuan, a year-on-year increase of 19.96%; net profit excluding non-recurring gains and losses was 1.628 billion yuan, a year-on-year increase of 24.98%; basic earnings per share were 0.62 yuan

    Zhitong·
    SH
    600873
    -0.30%
    Zhitong·
    SH
    600873
    -0.30%

    MEIHUABIO: The final consideration is 16.8 billion yen, completing the acquisition of the business delivery of amino acids and other products from Kyowa Hakko Bio

    On July 1st, MEIHUABIO announced that the company and its wholly-owned subsidiary PLUM BIOTECHNOLOGY GROUP PTE.LTD. have completed the business delivery of the "Share and Asset Purchase Agreement" signed with Kyowa Hakko Bio Co., Ltd., a wholly-owned subsidiary of Kirin Holdings Company, Limited

    Zhitong·
    SH
    600873
    -0.30%
    Zhitong·
    SH
    600873
    -0.30%

    MEIHUABIO: Has repurchased 35.7084 million shares, using a total of 352 million yuan

    On June 3rd, MEIHUABIO announced that the company's board of directors agreed to repurchase the company's shares through centralized bidding, with a repurchase amount not less than 300 million yuan and not exceeding 500 million yuan. The repurchased shares will be used for cancellation, reducing registered capital. As of the end of May 2025, the company had cumulatively repurchased 35.7084 million shares, accounting for 1.25% of the company's total share capital, with a repurchase price range of 9.1 yuan/share to 10.68 yuan/share, and a total of 352 million yuan used

    Zhitong·
    SH
    600873
    -0.30%
    Zhitong·
    SH
    600873
    -0.30%

    MEIHUABIO released its first-quarter performance, with a net profit attributable to the parent company of 1.019 billion yuan, a year-on-year increase of 35.52%

    MEIHUABIO released its Q1 2025 performance report, with operating revenue of 6.269 billion yuan, a year-on-year decrease of 3.36%; net profit attributable to the parent company of 1.019 billion yuan, a year-on-year increase of 35.52%; net profit after deducting non-recurring gains and losses of 905 million yuan, a year-on-year increase of 42.07%; basic earnings per share of 0.36 yuan/share

    Zhitong·
    SH
    600873
    -0.30%
    Zhitong·
    SH
    600873
    -0.30%
    © 2025 Longbridge｜Disclaimer